Agnieszka Smylnycky, MD
Family Medicine · Troy, MINPI 1346250578
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.
Across 104 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$317
- Novo Nordisk$286
- AbbVie$233
- Pfizer$225
- Lilly USA, LLC$141
- Exact Sciences$84
- plus $546 from 17 others
What the payments were for
- Food & beverage$1,832100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 20 | $317 |
| Novo Nordisk | 16 | $286 |
| AbbVie | 13 | $233 |
| Pfizer | 13 | $225 |
| Lilly USA, LLC | 8 | $141 |
| Exact Sciences | 3 | $84 |
| Abbott | 3 | $72 |
| Shield Therapeutics Inc | 3 | $62 |
| Nestle Healthcare Nutrition Inc. | 3 | $58 |
| Johnson & Johnson | 3 | $47 |
| Boehringer Ingelheim | 3 | $45 |
| GSK | 3 | $39 |
| Astellas Pharma US Inc | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Harmony Biosciences LLC | 1 | $24 |
| Bausch Health US, LLC | 1 | $22 |
| Redhill Biopharma Inc. | 1 | $20 |
| Aprecia Pharmaceuticals, LLC | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Medicomp Inc | 1 | $12 |
How this compares
$1,832 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 53 | $62,878 |
| EliquisApixaban | 26 | $33,496 |
| TrulicityDulaglutide | 27 | $31,751 |
| OzempicSemaglutide | 24 | $26,446 |
| XareltoRivaroxaban | 15 | $20,928 |
| MounjaroTirzepatide | 19 | $20,239 |
| RybelsusSemaglutide | 14 | $14,760 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $8,861 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $7,757 |
| Repatha SyringeEvolocumab | 13 | $6,905 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,887 |
| BrilintaTicagrelor | 11 | $4,697 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $4,655 |
| Diclofenac Sodium | 95 | $3,464 |
| Epinephrine | 11 | $3,444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $45 | $62,87853 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $141 | $51,99046 claims |
| Novo NordiskOzempic, Rybelsus | $286 | $41,20638 claims |
| PfizerEliquis | $225 | $33,49626 claims |
| Johnson & JohnsonXarelto | $47 | $20,92815 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $39 | $17,80743 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Troy
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
- Timothy IzzoGrand Ledge$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.